JPS6124518A - Remedy for hermorrhoids - Google Patents

Remedy for hermorrhoids

Info

Publication number
JPS6124518A
JPS6124518A JP59145103A JP14510384A JPS6124518A JP S6124518 A JPS6124518 A JP S6124518A JP 59145103 A JP59145103 A JP 59145103A JP 14510384 A JP14510384 A JP 14510384A JP S6124518 A JPS6124518 A JP S6124518A
Authority
JP
Japan
Prior art keywords
acid
action
hemorrhoids
remedy
linoleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59145103A
Other languages
Japanese (ja)
Other versions
JPH0568448B2 (en
Inventor
Kenji Hara
健次 原
Takahiro Futami
二見 高弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP59145103A priority Critical patent/JPS6124518A/en
Publication of JPS6124518A publication Critical patent/JPS6124518A/en
Publication of JPH0568448B2 publication Critical patent/JPH0568448B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:A remedy for hemorrhoids containing linoleic acid, linolenic acid, eicosapentaenoic acid, etc. as an active ingredient. CONSTITUTION:0.1-100wt% linoleic acid, linolenic acid, eicosapentaenoic acid and their glycerin esters is blended with an antioxidant substance (e.g., dl-alpha- tocopherol, nordihyroguaiaretic acid, buthylhydroxyanisole, etc.), to give a remedy for hemorrhoids. The remedy can be mixed with a drug having analgesic action, antipruritic action, sterilizing action, anti-inflammatory action, locally styptic action, etc. A suppository, ointment, spray using an oil base, etc. may be used as a dosage form for administration. The action of the active ingredient is considered to improve blood circulation in the varix of the surrounding parts of the anus, which is the cause of hermorrhoids.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は新規な痔疾治療剤に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to a novel therapeutic agent for hemorrhoids.

〔従来の技術〕[Conventional technology]

痔疾患は、日本人に多いとされており、食、生活、排便
体位、妊娠、日本式生性などが原因で紡発されると考え
られている。その治療薬は、全開、軟膏、内服薬等多様
で、これらには有効成分として鎮痛、鎮痒作用、殺菌作
用、消炎作用、局所止血作用、感染防御作用、末梢血液
促進作用、創傷治癒作用、抗アレルギー作用、細胞、組
織賦活作用咎を有する薬剤が配合されており、理論的に
は痔疾治療に有効なはずのものといえる。
Hemorrhoid disease is said to be common among Japanese people, and is thought to be caused by factors such as diet, lifestyle, defecation position, pregnancy, and Japanese-style birth control. Therapeutic drugs are diverse, such as Zenkai, ointments, and oral medications, and these include active ingredients such as analgesic, antipruritic, bactericidal, antiinflammatory, local hemostasis, infection prevention, peripheral blood promotion, wound healing, and antiallergy. It contains a drug that has active effects on cells and tissues, so it can be said that it should theoretically be effective in treating hemorrhoids.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

しかしなから、これらの治療薬は、実際上の治療効果の
点では未だ満足できるものではなかった。
However, these therapeutic agents have not yet been satisfactory in terms of their practical therapeutic effects.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者は、斯かる実状に鑑み、痔疾症状の軽減、治療
に有効な痔疾治療剤を得んと鋭意研究した結果、リノー
ル酸、リノレン酸、エイコサペンタエン酸、ドコサヘキ
サエン酸等を有効成分として使用すれば、痔疾の予防・
治療に極めて有効な痔疾治療剤が有られることを見出し
、第一発明を完成した。史に、この痔疾治療剤に抗酸化
物質を併用すればなお一層治療効果が島められること全
見出し、第二発明を完成した。
In view of this situation, the present inventor conducted extensive research to obtain a hemorrhoid treatment agent that is effective in alleviating and treating hemorrhoid symptoms, and as a result, the inventors used linoleic acid, linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, etc. as active ingredients. If you do this, you can prevent hemorrhoids.
The inventors have discovered that there is a therapeutic agent for hemorrhoids that is extremely effective for treatment, and have completed the first invention. In history, he discovered that the therapeutic effect of this hemorrhoid treatment agent can be further enhanced by combining it with an antioxidant, and completed the second invention.

すなわち不発明の第一発明は、リノール酸、’)/ し
”W%  エイコサペンタエン酸、ドコサヘキサエン酸
及びこれらのグリセリンエステルからなる群から遺ばれ
る一種又は二極以上を有効成分として含有する痔疾治療
剤を提供するものでろる。
That is, the first uninvented invention is a therapeutic agent for hemorrhoids containing as an active ingredient one or more of the following from the group consisting of linoleic acid, eicosapentaenoic acid, docosahexaenoic acid, and glycerin esters thereof. It is something that provides.

更に1本発明の第二発明は、抗飯化物質並びにリノール
酸、リノレン酸、エイコサペンタエン酸、ドコサヘキサ
エン酸及びこれらのグリセリンエステルからなる群から
選ばれる一種又は二種以上を有効成分として官有する5
−#挟治療剤を提供するものでるる。
Furthermore, the second invention of the present invention has as an active ingredient one or more selected from the group consisting of an anti-inflammatory substance and linoleic acid, linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, and glycerin esters thereof.
- #Provides therapeutic agents.

本発明に用いるリノール酸、リノレン酸は、天然トリグ
リセリドの加水分解、分別等の公知の方法で得ることが
できる。また、リノール酸モノグリセリド、リノール酸
モノグリセリドは、α−モノグリセリドでもβ−七ソノ
グリセリドも良く、天然モノグリセリドの分取、エステ
ル化、エステル交換、あるいは対応するトリグリセリド
、ジグリセリドの部分、7JII水分解等の公知の方法
で得ることができる。
Linoleic acid and linolenic acid used in the present invention can be obtained by known methods such as hydrolysis and fractionation of natural triglycerides. In addition, linoleic acid monoglyceride and linoleic acid monoglyceride may be α-monoglyceride or β-7sonoglyceride, and may be prepared by fractionation, esterification, transesterification of natural monoglyceride, or the corresponding triglyceride, diglyceride portion, 7JII water decomposition, etc. It can be obtained in this way.

本発明に用いるリノール酸等の不飽和カルボン酸のグリ
セリンエステルとしては、シ若シくはモノエステルが、
就中モノエステルがが好適である。
As the glycerin ester of unsaturated carboxylic acid such as linoleic acid used in the present invention, monoester or monoester can be used.
Among these, monoesters are preferred.

本発明の痔疾治療剤へのリノール酸、リノレン酸、エイ
コサペンタエン酸、ドコサペンタエン酸及びこれらのグ
リセリンエステルの配合量は、特に制限はなく、o、 
i〜100重量%(以下、%で示す〕である。
The amounts of linoleic acid, linolenic acid, eicosapentaenoic acid, docosapentaenoic acid, and glycerin esters thereof to be added to the hemorrhoid treatment agent of the present invention are not particularly limited, and include o,
i to 100% by weight (hereinafter expressed as %).

本発明の痔疾治療剤は、これに抗酸化物質を配合するこ
とKより、史にその治療効果を茜めることができる。か
かる目的で使用される抗酸化物質は、一般に化粧品、医
薬部外品、医薬品等で汎用されるものでよく、例えばd
t−α−トコフェロール、ノルジヒトログアセレチン酸
、ブチルヒドロキシアニソール、シブチルヒドロキシト
ルエン、没食子酸ゾロビル、エリソルビン酸、エリソル
ビン酸ナトリウム、抗酸化能を有する生薬抽出物等が挙
けられる。抗酸化能を有する生薬抽出物としては、例え
ばオールスノQイス、アニス(茄香、ウィキョウ〕、パ
ゾル、キャラクエー、カルダモン、シナモン(桂皮)、
クローブ(丁字)、コリアン〆−(&I)、フェンネル
、ガーリック(大蒜〕、シンシャー(主要)、サンショ
ウ、ペイリープス、マスタード、ナツメグ(肉豆洩)、
オニオン(玉葱)、ノQセリ、ヘノQ−、サフラン、ロ
ーズマリー、サルビア、タイム、ターメリンク(前金)
、バニラ、/eノリ力、クローブ、胡麻、ヨクイニン、
柴胡、黄連、五味子、五倍子、厚朴、大量、出英炙、牡
丹皮等が例示されるが、就中、ローズマリー、サルビア
、オールスノqイス、ノqシリカ、胡麻、タイムが好ま
しい。
By adding an antioxidant to the hemorrhoid treatment agent of the present invention, its therapeutic effect can be further enhanced. Antioxidants used for this purpose may be those commonly used in cosmetics, quasi-drugs, pharmaceuticals, etc., such as d
Examples include t-α-tocopherol, nordihydroguaceretic acid, butylated hydroxyanisole, sibutylated hydroxytoluene, zolobyl gallate, erythorbic acid, sodium erythorbate, crude drug extracts having antioxidant ability, and the like. Examples of crude drug extracts with antioxidant ability include All Suno Q-isu, anise, pasol, caraque, cardamom, cinnamon,
Clove (Choji), Korean paste (&I), fennel, garlic (garlic), sinshar (main), sardine, pepper, mustard, nutmeg,
Onion, NoQ Seri, Heno Q-, Saffron, Rosemary, Salvia, Thyme, Turmelink (premium)
, vanilla, / e Nori Chikara, clove, sesame, yokuinin,
Examples include saiko, huanglian, schisandra, gobaiko, thick boku, large quantity, zuei broiled, and peony, among which rosemary, salvia, allsnos, silica, sesame, and thyme are preferred.

抗酸化物質は、リノール酸、リノレン酸、エイコサペン
タエン酸、ドコサペンタエン酸及びこれらのグリセリン
エステルの0゜1〜10X配合するのが好ましい。
The antioxidant is preferably 0.1 to 10X of linoleic acid, linolenic acid, eicosapentaenoic acid, docosapentaenoic acid, and their glycerin esters.

更忙本発明の痔疾治療剤には、上記の有効成分のほかに
、例えば鎮痛作用、鎮痒作用、殺菌作用、消炎作用、局
所止血作用、感染防御作用、末梢血液促進作用、創傷治
癒作用、抗アレルギー作用、細胞、組織賦活作用を有す
る既存の薬剤などを配合して、用いることも可能である
In addition to the above-mentioned active ingredients, the hemorrhoid treatment agent of the present invention has, for example, analgesic action, antipruritic action, bactericidal action, anti-inflammatory action, local hemostatic action, infection prevention action, peripheral blood promoting action, wound healing action, and anti-inflammatory action. It is also possible to mix and use existing drugs that have allergic effects and cell and tissue activating effects.

投与方法としては、全開、軟膏、油性基剤を用いたスプ
レー等として投与する方法が挙けられる。
Examples of administration methods include administration as a full-stripe solution, an ointment, a spray using an oily base, and the like.

〔作用〕[Effect]

本発明に使用されるリノール酸、リノレン酸、エイコサ
ペンタエン酸、ドコサペンタエン酸及びこれらのグリセ
リンエステルが痔疾治療に有効性を発揮するメカニズム
#i明らかではないが、痔疾の原因である肛門周辺部の
静脈瘤のうつ血を改善し、局所の血行を促進するためと
考えられる。
Mechanism by which linoleic acid, linolenic acid, eicosapentaenoic acid, docosapentaenoic acid, and their glycerin esters used in the present invention are effective in treating hemorrhoids #i Although it is not clear, the mechanism by which linoleic acid, linolenic acid, eicosapentaenoic acid, docosapentaenoic acid, and their glycerin esters are effective in treating hemorrhoids #i Although it is not clear, the perianal area, which is the cause of hemorrhoids, This is thought to improve the congestion of varicose veins and promote local blood circulation.

〔発明の効果〕〔Effect of the invention〕

本発明の痔疾治療剤は、後記実施例に示した如く、痔疾
治療に有効なものである。
The therapeutic agent for hemorrhoids of the present invention is effective in treating hemorrhoids, as shown in the Examples below.

〔実施例〕〔Example〕

次に実施例を挙りて本発明を説明する◎実施例1 組 成: ■ リノール&         98.95重量部■
 ヒドロコルチゾン      0.05■ 酢酸dt
−トコフェロール   1.00■〜■を45℃にて加
温し、よく混合したのち500#v宛ソフトゼラチンに
充填し、痔疾治療用ソフトゼラチン・カプセル剤と・し
た。
Next, the present invention will be explained with reference to examples.◎Example 1 Composition: ■Linole & 98.95 parts by weight■
Hydrocortisone 0.05■ Acetic acid dt
-Tocopherols 1.00■~■ were heated at 45°C, mixed well, and then filled into 500#v soft gelatin to prepare soft gelatin capsules for hemorrhoid treatment.

本発明品を痔疾患者20名に1日1回2個宛ziM間使
用してもらった。症状の変化#′i表1に示す通りであ
り、かなり症状の軽減が観察された。
The product of the present invention was used by 20 people suffering from hemorrhoids once a day for ziM. Change in symptoms #'i As shown in Table 1, a considerable reduction in symptoms was observed.

表1 実施例2 組  成: ■  リノール酸モノグリセリド     i o、o
 x置部■ ゾレドニゾロン          0.
05■ アミノ安息香酸エチル       0.5■
  dl−α−トコフェロール      1.0計1
00 ■〜■を6θ℃にて加温し、よく混合したのち1.5f
宛坐剤製造用鋳型にて製剤化する。
Table 1 Example 2 Composition: ■ Linoleic acid monoglyceride io, o
xOkibe ■ Zolednisolone 0.
05■ Ethyl aminobenzoate 0.5■
dl-α-tocopherol 1.0 total 1
00 ■~■ were heated at 6θ℃, mixed well, and then heated to 1.5f.
Formulate into a mold for making suppositories.

実施例3 組成: ■ ワセリン           lO1θ重景部置
部  ラノリ7           4.5、■  
インゾロビルミリステート5,0■  リノール畝モノ
グリセリド     1O10■  リノール酸   
       5.0■ 安息香酸ゾロビルエステル 
   0.1゛■  ソルビタンモノステアレート  
  2.0■  クリセロールモノステアレート   
2,0■ 精製水            バランス計
100 ■■を70℃で加温してゆるやかにかきまぜながら、同
じ(70’CK加温した■〜■を徐々に添加し乳化する
。次いで、これを冷却して痔疾軟膏とする@ 本発明品を肛門周辺部にかゆみを有する軽度の痔疾患者
10名に、毎日風呂上りに使用してもらったところ、3
〜5日で全員にかゆみが消失した。
Example 3 Composition: ■ Vaseline lO1θ Heavy View Part Lanoli 7 4.5, ■
Inzolovir myristate 5,0■ Linole ridge monoglyceride 1O10■ Linoleic acid
5.0 ■ Zorobyl benzoate ester
0.1゛■ Sorbitan monostearate
2.0■ Criserol monostearate
2.0 ■ Purified water Balance meter 100 ■■ is heated to 70℃, and while gently stirring, gradually add the same (70'CK heated ■~■) and emulsify it.Next, cool this and Used as a hemorrhoid ointment @ Ten people with mild hemorrhoids who have itching around the anus used the product every day after taking a bath.
Itching disappeared in all patients in ~5 days.

実施例4 0−ズマリー・アセトン抽出物を製造し、これを用いて
下記組成の痔疾治療剤を調製した。
Example 4 An acetone extract of 0-zumary was produced, and a therapeutic agent for hemorrhoids having the following composition was prepared using the extract.

ローズマリー・アセトン抽出物: ローズマリー粉末lKyにアセトン3に〕を加え、室温
で3時間抽出後、抽出液をp遇する。
Rosemary acetone extract: Add 3 parts of acetone to rosemary powder, extract at room temperature for 3 hours, and then pour the extract.

このp液をロータリーエバポレーターにて濃縮、浴媒を
完全に除去すると、抗酸化能を有するローズマリー抽出
物170fを得る。
By concentrating this p liquid using a rotary evaporator and completely removing the bath medium, a rosemary extract 170f having antioxidant ability is obtained.

組成: ■ リノレン酸       50,01量部■ シリ
コーン        20.0■ ローズ・マリ−ア
セトン抽出物 05■ スクワレン       29
.5■■■を50℃に加温し、よく混合したのちt室温
まで冷却し・■を加えよく攪拌する。
Composition: ■ Linolenic acid 50.01 parts ■ Silicone 20.0 ■ Rose mariacetone extract 05 ■ Squalene 29
.. 5. Heat the ■■■ to 50°C, mix well, then cool to room temperature, add the ■■, and stir well.

本発明品は、これをスプレーボトルに充填し、次の方法
にて使用する\。すなわち、痔疾患者において、排便後
おるいは入浴後、不発明品を用いて、肛門周辺部及び痔
疾患部をぬぐう方法にて使用する。本発明品を内痔核を
有する痔疾患者10名に排便後、通常どおりトイレット
ペー/Q−で清拭したのち、肛門周辺部を本発明品をス
ゾレーしたトイレットペーノq−でぬぐってもらった。
The product of the present invention is filled into a spray bottle and used in the following manner. That is, in a person suffering from hemorrhoids, the uninvented product is used to wipe the area around the anus and areas affected by hemorrhoids after defecation or after bathing. After using the product of the present invention on 10 hemorrhoid patients with internal hemorrhoids who had defecated, they wiped it with toilet paper/Q- as usual, and then wiped the anal area with toilet paper/Q- containing the product of the present invention.

その結果、鉦状の変化は表2に示すとおりであり、かな
りの症状の軽減が観察された。
As a result, the gong-shaped changes were as shown in Table 2, and a considerable reduction in symptoms was observed.

表2 実施例5 組成: ■  酢酸dt−)コフエロール     10.0■
〜■を45℃にて加温し、よく混合したのち、330W
宛ソフトゼラチンカプセルに充填し、痔疾治療用ソフト
ゼラチン・カプセル剤とした。
Table 2 Example 5 Composition: ■ dt-)copherol acetate 10.0■
After heating ~■ at 45℃ and mixing well, 330W
The product was filled into soft gelatin capsules to prepare soft gelatin capsules for the treatment of hemorrhoids.

本発明品を軽度の痔疾患者10名(内痔核1度の者)に
1日2回2個宛1週間使用してもらった。その結果痔疾
の症状にすべて改善がみられた。
The product of the present invention was used by 10 people with mild hemorrhoid disease (individuals with 1st grade internal hemorrhoids) using 2 pieces twice a day for 1 week. As a result, all symptoms of hemorrhoids improved.

実施例6 実施例5のエイコサペンタエンm、ド:ytヘキサエン
酸混合物の代りにエイコサペンタエン酸、ドコサヘキサ
エン酸の混合脂肪酸を構成脂肪酸とするモノグリセライ
ドを用いて製剤化した場合も実施例5同様の効果を得た
Example 6 The same effects as in Example 5 were obtained when a monoglyceride containing a mixed fatty acid of eicosapentaenoic acid and docosahexaenoic acid as a constituent fatty acid was used instead of the eicosapentaenoic m, do:yt hexaenoic acid mixture in Example 5. Obtained.

以上that's all

Claims (1)

【特許請求の範囲】 1、リノール酸、リノレン酸、エイコサペンタエン酸、
ドコサヘキサエン酸及びこれらのグリセリンエステルか
らなる群より選ばれる一種又は二種以上を有効成分とし
て含有することを特徴とする痔疾治療剤。 2、抗酸化物質並びにリノール酸、リノレン酸、エイコ
サペンタエン酸、ドコサヘキサエン酸及びこれらのグリ
セリンエステルからなる群より選ばれる一種又は二種以
上を有効成分として含有することを特徴とする痔疾治療
剤。
[Claims] 1. Linoleic acid, linolenic acid, eicosapentaenoic acid,
A therapeutic agent for hemorrhoids, characterized in that it contains one or more selected from the group consisting of docosahexaenoic acid and their glycerin esters as an active ingredient. 2. A therapeutic agent for hemorrhoids, which contains as an active ingredient one or more antioxidants and one or more selected from the group consisting of linoleic acid, linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, and glycerin esters thereof.
JP59145103A 1984-07-12 1984-07-12 Remedy for hermorrhoids Granted JPS6124518A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59145103A JPS6124518A (en) 1984-07-12 1984-07-12 Remedy for hermorrhoids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59145103A JPS6124518A (en) 1984-07-12 1984-07-12 Remedy for hermorrhoids

Publications (2)

Publication Number Publication Date
JPS6124518A true JPS6124518A (en) 1986-02-03
JPH0568448B2 JPH0568448B2 (en) 1993-09-29

Family

ID=15377441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59145103A Granted JPS6124518A (en) 1984-07-12 1984-07-12 Remedy for hermorrhoids

Country Status (1)

Country Link
JP (1) JPS6124518A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501308A (en) * 1986-11-06 1989-05-11 ラボラトワール・ナチュラ・メディカ A therapeutic composition comprising α-linolenic acid and a compound capable of promoting passage of the acid through cell membranes, a plant extract comprising the acid and compound, and a method for producing the extract.
ES2144945A1 (en) * 1998-03-05 2000-06-16 Vidal Nadal Florencio Haemorrhoid treatment product composition
US7981877B2 (en) * 2003-01-23 2011-07-19 Patel Pravin M Stabilized steroid composition and method for its preparation
EP3811958A4 (en) * 2018-06-21 2022-04-20 Laboratorios Abbap Pharma S.L. Composition for the prevention and/or treatment of haemorrhoids

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501308A (en) * 1986-11-06 1989-05-11 ラボラトワール・ナチュラ・メディカ A therapeutic composition comprising α-linolenic acid and a compound capable of promoting passage of the acid through cell membranes, a plant extract comprising the acid and compound, and a method for producing the extract.
ES2144945A1 (en) * 1998-03-05 2000-06-16 Vidal Nadal Florencio Haemorrhoid treatment product composition
US7981877B2 (en) * 2003-01-23 2011-07-19 Patel Pravin M Stabilized steroid composition and method for its preparation
EP3811958A4 (en) * 2018-06-21 2022-04-20 Laboratorios Abbap Pharma S.L. Composition for the prevention and/or treatment of haemorrhoids

Also Published As

Publication number Publication date
JPH0568448B2 (en) 1993-09-29

Similar Documents

Publication Publication Date Title
US20070105954A1 (en) Formulation containing a carboxylic acid or an ester thereof
JP3065530B2 (en) Pharmaceutical base, pharmaceutical preparation method, pharmaceutical composition, drug, pharmaceutical material and cosmetic product
HUE026929T2 (en) A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol
US3322626A (en) Medicinal composition for treating acne and method of using same
AU2001260833B2 (en) Treating eczema and/or psoriasis
JPH02174719A (en) Percutaneously administrative drug composition containing steroin and/or spiroketaline
JPS6124518A (en) Remedy for hermorrhoids
US6407085B1 (en) Medicament containing betasitosterol and/or phytosterol/betasitosterol mixtures
US8586064B2 (en) Treating eczema and/or psoriasis
WO2001047525A1 (en) Antipruritic agents for external use
RU2233152C1 (en) Anti-inflammatory and anti-itching cream for treatment of dermatological disease
JP4791682B2 (en) Acupuncture treatment
JP2005075755A (en) Antiphlogistic-sedative plaster and method for producing the same
AU2004315561B2 (en) External preparation for treating painful skin wound
RU2097022C1 (en) Suppository showing antiinflammatory effect
CN100443088C (en) Medicinal preparation for treating gynecologic blood diseases and inflammation
CN1132596C (en) Chinese medicine 'Zhidakang' for treating haemorrhoids and its preparing process
JPH0259519A (en) Remedy for skin inflammation
TW200528091A (en) External preparation for treatment of skin wound with pain
CN1095278A (en) Tripterygium wilfordii plaster
JPS61103826A (en) Anti-inflammatory agent
TW200528115A (en) External preparation for treatment of skin or mucous membrane injury due to virus infection
US20060008536A1 (en) Pharmaceutical compositions and methods of use
EP1700597B1 (en) Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application
JP2004292341A (en) External preparation for inhibiting formation of keloid, and the like